Literature DB >> 28248444

Peri-levator palpebrae superioris triamcinolone injection for the treatment of thyroid eye disease-associated upper eyelid retraction.

Zachary P Joos1, Timothy J Sullivan1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28248444     DOI： 10.1111/ceo.12939

Source DB:  PubMed          Journal:  Clin Exp Ophthalmol        ISSN： 1442-6404            Impact factor:   4.207


× No keyword cloud information.
  5 in total

1.  Shallow periorbital injection of triamcinolone acetonide in treatment of lower eyelid entropion related to thyroid-associated ophthalmopathy: Three case reports.

Authors:  Fei Mo; Dongdong Xu; Haiyan Xu; Gang Li; Yizhuo Gao; Hui Li
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.889

2.  Medical management of thyroid eye disease - A paradigm shift.

Authors:  Santosh G Honavar
Journal:  Indian J Ophthalmol       Date:  2020-08       Impact factor: 1.848

3.  Observations on the Efficacy of Two Methods for the Treatment of Upper Eyelid Retraction in Thyroid-Associated Ophthalmopathy.

Authors:  Dongping Li; Fengyuan Sun
Journal:  Biomed Res Int       Date:  2021-03-18       Impact factor: 3.411

Review 4.  Management of eyelid retraction related to thyroid eye disease.

Authors:  Tammy H Osaki; Lucas G Monteiro; Midori H Osaki
Journal:  Taiwan J Ophthalmol       Date:  2022-02-14

Review 5.  Local delivery of corticosteroids in clinical ophthalmology: A review.

Authors:  Adrian T Fung; Tuan Tran; Lyndell L Lim; Chameen Samarawickrama; Jennifer Arnold; Mark Gillies; Caroline Catt; Logan Mitchell; Andrew Symons; Robert Buttery; Lisa Cottee; Krishna Tumuluri; Paul Beaumont
Journal:  Clin Exp Ophthalmol       Date:  2020-01-22       Impact factor: 4.207
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.